Melanoma Journal Articles for January 2017
Computation 2017, 5(1), 4; doi:10.3390/computation5010004
An SVM Framework for Malignant Melanoma Detection Based on Optimized HOG Features
J Immunother. 2016 Jan; 39(1): 15–26.
doi: 10.1097/CJI.0000000000000103
Identification of melanoma-reactive CD4+ T cell subsets from Human Melanoma Draining Lymph Nodes
Mei Zhang,1,2,3 Hallie Graor,3 Lu Yan,1 and Julian Kim
Which symptoms are linked to a delayed presentation among melanoma patients? A retrospective study
Sally Jane O’Shea, Zoe Rogers, Fiona Warburton, Amanda J. Ramirez, Julia A. Newton-Bishop and Lindsay J. L. Forbes
BMC Cancer201717:5
DOI: 10.1186/s12885-016-2978-6
Received: 30 November 2015
Accepted: 29 November 2016
Published: 3 January 2017
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
Julia Escandon, Stephanie Peacock, Asaad Trabolsi, David B. Thomas, Ayman Layka and Jose Lutzky
Journal for ImmunoTherapy of Cancer20175:3
DOI: 10.1186/s40425-016-0205-2
Received: 27 June 2016
Accepted: 15 December 2016
Published: 17 January 2017
BioRxiv
Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature
Johan Fredriksson, Kerryn Eliot, Stefan Filges, Anders Stahlberg, Erik Larsson
doi: https://doi.org/10.1101/069351
Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations
Stephen K Horrigan, Pascal Courville, Darryl Sampey, Faren Zhou, Steve Cai,
- Reproducibility Project: Cancer Biology
Noble Life Sciences, United States; BioFactura, United States; TACGen, United States
DOI: http://dx.doi.org/10.7554/eLife.21634
Published January 19, 2017
Cite as eLife 2017;6:e21634
Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase
Katerina Nikolovska, Dorothe Spillmann, Jörg Haier, Andrea Ladányi, Christian Stock, Daniela G. Seidler
- Published: January 20, 2017
- http://dx.doi.org/10.1371/journal.pone.0170054
Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma
- Aamir Zainulabadeen,
- Philip Yao,
- Habil Zare
- Published: January 23, 2017
- http://dx.doi.org/10.1371/journal.pone.0170025
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells
Souvik Banerjee, Derek D. Norman, Sue Chin Lee, Abby L Parrill, Truc Chi T. Pham, Daniel L. Baker, Gabor G. Tigyi, and Duane D Miller
- Med. Chem., Just Accepted Manuscript
DOI: 10.1021/acs.jmedchem.6b01270
Publication Date (Web): January 23, 2017
Copyright © 2017 American Chemical Society
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy.
Liechtenstein T., Perez-Janices N., Blanco-Luquin I., Goyvaerts C., Schwarze J., Dufait I., Lanna A., Ridder M., Guerrero-Setas D., Breckpot K., Escors D.
Oncoimmunology
BOOK
Chapter
pp 39-61
Date: 26 January 2017
Melanoma Epidemiology
Marianne Berwick
Ipilimumab Adjuvant Therapy in Melanoma
G Ianiro et al. N Engl J Med 376 (4), 398. 2017 Jan 26.
PubMed: 28125193
Epigenomes 2017, 1(1), 3; doi:10.3390/epigenomes1010003
New Frontiers in Melanoma Epigenetics—The More We Know, the More We Don’t Know
Marzena Nguyen and Paula Dobosz
Received: 31 December 2016 / Accepted: 25 January 2017 / Published: 30 January 2017
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
Authors Krantz BA, Dave N, Komatsubara KM, Marr BP, Carvajal RD
Received 30 August 2016
Accepted for publication 22 November 2016
Published 31 January 2017 Volume 2017:11 Pages 279—289
DOI https://doi.org/10.2147/OPTH.S89591